Medicines Development for Global Health   Report issue

For profit Phase 1 Phase 3
Founded: Melbourne Australia (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2010
NCT01123915
First Marketed Drug
2018
moxidectin
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MDGH | Medicines Development for Global Health | Medicines Development Limited